Mitochondrial pathology in muscle of a patient with a novel parkin mutation

International Journal of Neuroscience

Volumn 119, Issue 10, 2009, Pages 1572-1583

  Hanagasi, Hasmet A ^a   Serdaroglu, Piraye ^a   Ozansoy, Mehmet ^b   Basak, Nazli ^b   Tasli, Hatice ^a   Emre, Murat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BOGAZICI UNIVERSITY   (Turkey)

Author keywords

COX deficiency; Mitochondria; Muscle; Parkin mutation; Parkinson's disease

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; CYTOCHROME C OXIDASE; ENTACAPONE; LEVODOPA; PARKIN; PERGOLIDE;

ADULT; ARTICLE; BICEPS BRACHII MUSCLE; BRADYKINESIA; CASE REPORT; CHROMOSOME 6; CYTOCHROME C OXIDASE DEFICIENCY; DYSKINESIA; ELECTROMYOGRAPHY; FOLLOW UP; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; HOMOZYGOSITY; HUMAN; MALE; MUSCLE BIOPSY; MUSCLE HYPERTROPHY; MUSCLE MITOCHONDRION; MUSCLE RIGIDITY; MYOPATHY; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; RATING SCALE; TREATMENT RESPONSE; TREMOR;

ELECTRON TRANSPORT COMPLEX IV; FAMILY HEALTH; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; MUTATION; PARKINSONIAN DISORDERS; SUCCINATE DEHYDROGENASE; UBIQUITIN-PROTEIN LIGASES;

EID: 70350434308     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450903088019     Document Type: Article

References (30)

1. Abbruzzese, G., Pigullo, S., Schenone, A., Bellone, E., Marchese, R., Di Maria, E., et al. (2004). Does parkin play a role in the peripheral nervous system? A family report. Movement Disorders, 19, 978-981.
2. Casali, C., Bonifati, V., Santorelli, F. M., Casari, G., Fortini, D., Patrignani, A., et al. (2001).Mitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a Sephardic Jewish family. Neurology, 56, 802-805.
3. Darios, F., Corti, O., Lucking, C. B., Hampe, C., Muriel, M. P., Abbas, N., et al. (2003). Parkin prevents mitochondrial swelling and cytochrome c release in mitochondriadependent cell death. Human Molecular Genetics, 12, 517-526.
4. DiMauro, S., Tanji, K., Bonilla, E., Pallotti, F., & Schon, E. A. (2002). Mitochondrial abnormalities in muscle and other aging cells: Classification, causes, and effects. Muscle Nerve, 26, 597-607.
5. Dogu, O., Johnson, J., Hernandez, D., Hanson, M., Hardy, J., Apaydin, H., et al. (2004). A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion. Movement Disorders, 19, 812-816.
6. Fahn, S., Elton, R. L., & members of the UPDRS Development Committee. (1987). Unified Parkinson's disease rating scale. In S. Fahn, C. D. Marsden, M. Goldstein, and D. B. Calne (eds.), Recent Developments in Parkinson's Disease, Volume 2. Florham Park, NJ: Macmillan Healthcare Information, 153-163.
7. Gibb, W. R., & Lees, A. J. (1988). The relevance of the Lewy Body pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 51, 745-752.
8. Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003). Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proceedings of the National Academy of Sciences, 100, 4078-4083.
9. Hattori, N., & Mizuno, Y. (2004). Pathogenetic mechanisms of parkin in Parkinson's disease. Lancet, 364, 722-724.
10. Hedrich, K., Eskelson, C., Wilmot, B., Marder, K., Harris, J., Garrels, J., et al. (2004). Distribution, type, and origin of Parkin mutations: Review and case studies. Movement Disorders, 19, 1146-1157.
11. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17, 427-442.
12. Hyun, D. H., Lee, M. H., Hattori, N., Kubo, S. I., Mizuno, Y., Halliwell, B., et al. (2002). Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. The Journal of Biological Chemistry, 277, 28572-28577.
13. Kann, M., Jacobs, H., Mohrmann, K., Schumacher, K., Hedrich, K., Garrels, J., et al. (2002).Role of parkin mutations in 111 community-based patientswith early-onset parkinsonism. Annals of Neurology, 51, 621-625.
14. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., et al. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608. (Pubitemid 28207717)
15. Kuroda, Y., Mitsui, T., Kunishige, M., & Matsumoto, T. (2006b). Parkin affects mitochondrial function and apoptosis in neuronal and myogenic cells. Biochemical and Biophysical Research Communications, 348, 787-793.
16. Kuroda, Y., Mitsui, T., Kunishige, M., Shono, M., Akaike, M., Azuma, H., et al. (2006a). Parkin enhances mitochondrial biogenesis in proliferating cells. HumanMolecular Genetics, 15, 883-895.
17. Lohmann, E., Periquet, M., Bonifati, V., Wood, N. W., De Michele, G., Bonnet, A. M., et al. (2003). How much phenotypic variation can be attributed to parkin genotype? Annals of Neurology, 54, 176-185
18. Lucking, C. B., Durr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., et al. (2000). Association between early-onset Parkinson's disease and mutations in the parkin gene. The New England Journal of Medicine, 342, 1560-1567.
19. Matsumine, H., Saito, M., Shimoda-Matsubayashi, S., Tanaka, H., Ishikawa, A., Nakagawa-Hattori, Y., et al. (1997). Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. American Journal of Human Genetics, 60, 588-596.
20. Narendra, D., Tanaka, A., Suen, D. F., & Youle, R. J. (2008). Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. The Journal of Cell Biology, 183, 795-803.
21. Paciello, O., Wojcik, S., Engel, W. K., McFerrin, J., & Askanas, V. (2006). Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers. Acta Myologica, 25, 13-22.
22. Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., et al. (2004).Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. The Journal of Biological Chemistry, 279, 18614-18622.
23. Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., et al. (2006). Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature, 441, 1157-1161.
24. Periquet, M., Latouche, M., Lohmann, E., Rawal, N., De Michele, G., Ricard, S., et al. (2003). Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain, 126, 1271-1278.
25. Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., et al. (2004). Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development, 131, 2183-2194.
26. Rosen, K. M., Veereshwarayya, V., Moussa, C. E. H., Fu, Q., Goldberg, M. S., Schlossmacher, M. G., et al. (2006). Parkin protects against mitochondrial toxins and â-amyloid accumulation in skeletal muscle cells. The Journal of Biological Chemistry, 281, 12809-12816.
27. Serdaroglu, P., Tasli, H., Hanagasi, H. A., & Emre, M. (2005). Parkin expression in human skeletal muscle. Journal of Clinical Neuroscience, 12, 927-929.
28. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., et al. (2000). Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nature Genetics, 25, 302-305.
29. Simon, D. K., Pulst, S. M., Sutton, J. P., Browne, S. E., Beal, M. F., & Johns, D. R. (1999). Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology, 53, 1787-1793.
30. Winklhofer, K. F., Henn, I. H., Kay-Jackson, P. C., Heller, U., & Tatzelt, J. (2003). Inactivation of parkin by oxidative stress and C-terminal truncations: A protective role of molecular chaperones. The Journal of Biological Chemistry, 278, 47199-47208.